Inhibitory effects of Chelidonium majus extract on atopic dermatitis-like skin lesions in NC/Nga mice
- 1 November 2011
- journal article
- Published by Elsevier BV in Journal of Ethnopharmacology
- Vol. 138 (2), 398-403
- https://doi.org/10.1016/j.jep.2011.09.028
Abstract
No abstract availableKeywords
Funding Information
- Oriental Medical Science Center
This publication has 17 references indexed in Scilit:
- Chelidonium majus – an Integrative Review: Traditional Knowledge versus Modern FindingsForschende Komplementärmedizin / Research in Complementary Medicine, 2010
- Cytokines and chemokines orchestrate atopic skin inflammationJournal of Allergy and Clinical Immunology, 2006
- Scratching of their skin by NC/Nga mice leads to development of dermatitisLife Sciences, 2004
- Animal models for atopic dermatitis: are they relevant to human disease?Journal of Dermatological Science, 2004
- A comparative study on the anti-inflammatory, antinociceptive and antipyretic effects of isoquinoline alkaloids from the roots of Turkish Berberis speciesLife Sciences, 2002
- Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga miceInternational Immunology, 1997
- PHARMACOLOGICAL ACTIVITIES OFCHELIDONIUM MAJUSL. (PAPAVERACEAE)Pharmacological Research, 1996
- The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. III. Independent hospital validationBritish Journal of Dermatology, 1994
- Antiinflammatory Activity of Quaternary Benzophenanthridine Alkaloids fromChelidonoum majus*,**Planta Medica, 1981
- Biological and Phytochemical Evaluation of Plants V: Isolation of Two Cytotoxic Alkaloids From Chelidonium majusJournal of Pharmaceutical Sciences, 1969